Sequence-specific control of gene expression by antigene and clamp oligonucleotides
- PMID: 9383571
- DOI: 10.1002/9780470515396.ch8
Sequence-specific control of gene expression by antigene and clamp oligonucleotides
Abstract
Control of gene expression at the transcriptional level can be achieved with triplex-forming oligonucleotides provided that the target sequence is accessible within the chromatin structure of cell nuclei. Using oligonucleotide-psoralen conjugates as probes we have shown that the promoter region of the gene encoding the alpha subunit of the interleukin 2 receptor and the polypurine tract of integrated HIV provirus can form sequence-specific, triple-helical complexes in cell cultures. Oligonucleotide-intercalator conjugates can inhibit transcription initiation by competing with transcription factor binding. Oligonucleotide analogues containing N3'-->P5' phosporamidate linkages form stable triple helices that are able to arrest transcription at the elongation step. A triple helix can also be formed on a single-stranded target by clamp oligonucleotides. A clamp targeted to the polypurine tract of HIV RNA is able to block reverse transcription of the viral RNA.
Similar articles
-
Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.J Mol Biol. 2001 Feb 9;306(1):15-24. doi: 10.1006/jmbi.2000.4386. J Mol Biol. 2001. PMID: 11178890
-
Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation.Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4365-9. doi: 10.1073/pnas.93.9.4365. Proc Natl Acad Sci U S A. 1996. PMID: 8633072 Free PMC article.
-
Triple helix formation and the antigene strategy for sequence-specific control of gene expression.Biochim Biophys Acta. 1999 Dec 10;1489(1):181-206. doi: 10.1016/s0167-4781(99)00149-9. Biochim Biophys Acta. 1999. PMID: 10807007 Review.
-
The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.Biochimie. 1993;75(1-2):71-8. doi: 10.1016/0300-9084(93)90027-p. Biochimie. 1993. PMID: 7684936
-
Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.Biochim Biophys Acta. 1999 Dec 10;1489(1):131-40. doi: 10.1016/s0167-4781(99)00151-7. Biochim Biophys Acta. 1999. PMID: 10807003 Review.
Cited by
-
Cholesterol conjugated oligonucleotide and LNA: a comparison of cellular and nuclear uptake by Hep2 cells enhanced by streptolysin-O.Mol Cell Biochem. 2005 Aug;276(1-2):61-9. doi: 10.1007/s11010-005-2912-8. Mol Cell Biochem. 2005. PMID: 16132686
-
Unambiguous demonstration of triple-helix-directed gene modification.Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3084-8. doi: 10.1073/pnas.97.7.3084. Proc Natl Acad Sci U S A. 2000. PMID: 10716704 Free PMC article.
-
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.Mol Pathol. 2001 Aug;54(4):230-9. doi: 10.1136/mp.54.4.230. Mol Pathol. 2001. PMID: 11477137 Free PMC article.
-
Protein-free parallel triple-stranded DNA complex formation.Nucleic Acids Res. 2001 Feb 15;29(4):986-95. doi: 10.1093/nar/29.4.986. Nucleic Acids Res. 2001. PMID: 11160932 Free PMC article.
-
BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies.Int J Med Sci. 2012;9(5):339-52. doi: 10.7150/ijms.4414. Epub 2012 Jul 1. Int J Med Sci. 2012. PMID: 22811608 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous